Assessing the implementation of national sodium reduction policies in Nigeria: an interim qualitative evaluation of stakeholder perspectives.
Chisom Obiezu-Umeh, Vanessa Alfa, Clementina E Okoro...
https://pubmed.ncbi.nlm.nih.gov/41971375/Actively Recruiting
Led by Washington University School of Medicine · Updated on 2025-05-23
1350
Participants Needed
3
Research Sites
17 weeks
Total Duration
Researchers are evaluating the implementation and scale-up of Nigerias national sodium reduction program led by the Nigerian Agency for Food and Drug Administration and Control NAFDAC. This program uses the WHOs SHAKE package, which includes strategies like surveillance of salt intake, industry engagement, labeling standards, consumer education, and promoting healthy eating environments to reduce sodium intake and prevent hypertension. The study uses a type III hybrid, mixed methods design to assess the programs progress and effectiveness in real-world settings. The study involves enrolling adult household representatives from three Nigerian states to participate in repeated waves of data collection. Participants take part in surveys such as the STEPs survey, provide 24-hour and spot urine samples, blood samples for fatty acid estimation, and complete multiple 24-hour dietary recalls. These assessments occur at baseline Wave 1, and follow-ups at around 18 months Wave 2 and 36 months Wave 3 to monitor dietary sodium sources, population sodium intake, and program implementation outcomes. Participants will be involved in interviews, surveys, and biological sample collections over the study period. Researchers will use various frameworks and methods to evaluate program reach, adoption, feasibility, fidelity, acceptability, and cost. Key outcomes include changes in mean population sodium intake and 24-hour urinary sodium from baseline through follow-up waves, along with shifts in dietary sources of sodium and knowledge, attitudes, and behaviors about sodium intake. The total participation period spans approximately three years, with repeated assessments to track progress and impact.
CONDITIONS
Evaluating Implementation and Scale-Up of Nigeria's National Sodium Reduction Program
G
Guhan Iyer, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Washington University School of Medicine
Lead Sponsor
University of Abuja Teaching Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for eligibility assessment
Duration - Up to 36 months
Participants are enrolled as adult household representatives from three Nigerian states to complete surveys and biological sample collections across three waves to evaluate sodium intake and related behaviors.
3 visits at baseline, 18 months, and 36 months for surveys and sample collection
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Chisom Obiezu-Umeh, Vanessa Alfa, Clementina E Okoro...
https://pubmed.ncbi.nlm.nih.gov/41971375/Washington University School of Medicine
Lead Sponsor
University of Abuja Teaching Hospital
Collaborating Sponsor